Cargando…
Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313822/ http://dx.doi.org/10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc |
_version_ | 1782228033916108800 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3313822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33138222012-03-29 Correction: Predicting Tumor Responses to Gefitinib and Erlotinib PLoS Med Correction Public Library of Science 2012-03-05 /pmc/articles/PMC3313822/ http://dx.doi.org/10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc Text en Public Library of Science. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Correction Correction: Predicting Tumor Responses to Gefitinib and Erlotinib |
title | Correction: Predicting Tumor Responses to Gefitinib and Erlotinib |
title_full | Correction: Predicting Tumor Responses to Gefitinib and Erlotinib |
title_fullStr | Correction: Predicting Tumor Responses to Gefitinib and Erlotinib |
title_full_unstemmed | Correction: Predicting Tumor Responses to Gefitinib and Erlotinib |
title_short | Correction: Predicting Tumor Responses to Gefitinib and Erlotinib |
title_sort | correction: predicting tumor responses to gefitinib and erlotinib |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313822/ http://dx.doi.org/10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc |
work_keys_str_mv | AT correctionpredictingtumorresponsestogefitinibanderlotinib |